Influence of contrast ultrasonography with perflutren lipid microspheres on microvessel injury

Circulation Journal

Volumn 67, Issue 7, 2003, Pages 630-636

  Kobayashi, Nobuhiko ^a   Yasu, Takanori ^a   Yamada, Satoshi ^b   Kudo, Nobuki ^c   Kuroki, Masatoshi ^a   Miyatake, Kunio ^d   Kawakami, Masanobu ^a   Saito, Muneyasu ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Contrast agent; Endothelial cell; Microvessel; Perflutren; Ultrasound

Indexed keywords

CONTRAST MEDIUM; MICROSPHERE; PERFLUTREN; PROPIDIUM IODIDE; SHU 508;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD VESSEL INJURY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; ECHOGRAPHY; ENDOTHELIUM INJURY; FLUORESCENCE; HEART MUSCLE; MALE; MICROVASCULATURE; NONHUMAN; RAT;

EID: 0037593641     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.630     Document Type: Article

References (44)

1. Yoshitani H, Takeuchi M, Hirose M, Miyazaki C, Otani S, Sakamoto K, et al. Head-to-head comparison of fundamental, tissue harmonic and contrast harmonic imaging with or without an air-filled contrast agent, levovist, for endocardial border delineation in patients with poor quality images. Circ J 2002; 66: 494-498.
2. Takeuchi M, Yoshitani H, Miyazaki C, Otani S, Sakamoto K, Yoshikawa J. Assessment of myocardial perfusion by harmonic power doppler imaging at rest and during adenosine triphosphate stress: Comparison with coronary flow velocity reserve in the left anterior descending coronary arter. Circ J 2002; 66: 167-172.
3. Miller DL, Gies RA. Gas-body-based contrast agent enhances vascular bioeffects of 1.09 MHz ultrasound on mouse intestine. Ultrasound Med Biol 1998; 24: 1201-1208.
4. Dalecki D, Raeman CH, Child SZ, Cox C, Francis CW, Meltzer RS, et al. Hemolysis in vivo from exposure to pulsed ultrasound. Ultrasound Med Biol 1997; 23: 307-313.
5. Miller DL, Gies RA. The influence of ultrasound frequency and gas-body composition on the contrast agent-mediated enhancement of vascular bioeffects in mouse intestine. Ultrasound Med Biol 2000; 26: 307-313.
6. Schlief R, Schurmann R, Balzer T, Zomac M, Niendorf H. Saccharide based contrast agents. In: Nanda NC, Schlief R, editors. Advances in echo imaging using contrast enhancement. Dordrecht, The Netherlands: Kluwer Academic; 1993: 71-96.
7. Schneider M, Arditi M, Barrau MB, Brochot J, Broillet A, Ventrone R, et al. BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995; 30: 451-457.
8. Graybum PA, Weiss JL, Hack TC, Klodas E, Raichlen JS, Vannan MA, et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. J Am Coll Cardiol 1998; 32: 230-236.
9. Cohen JL, Cheirif J, Segar DS, Gillam LD, Gottdiener JS, Hausnerova E, et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. J Am Coll Cardiol 1998; 32: 746-752.
10. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998; 98: 290-293.
11. Kobayashi N, Yasu T, Yamada S, Kudo N, Kuroki M, Kawakami M, et al. Endothelial cell injury in venule and capillary induced by contrast ultrasonography. Ultrasound Med Biol 2002; 28: 949-956.
12. Van Der Wouw PA, Brauns AC, Bailey SE, Powers JE, Wilde AA. Premature ventricular contractions during triggered imaging with ultrasound contrast. J Am Soc Echocardiogr 2000; 13: 288-294.
13. Spencer KT, Bednarz J, Mor-Avi V, DeCara J, Lang RM. Automated endocardial border detection and evaluation of left ventricular function from contrast-enhanced images using modified acoustic quantification. J Am Soc Echocardiogr; 2002; 15: 777-781.
14. Porter TR, Xie F, Silver M, Kricsfeld D, Oleary E. Real-time perfusion imaging with low mechanical index pulse inversion Doppler imaging. J Am Coll Cardiol 2001; 37: 748-753.
15. Rosenberg ML, Carpenter AP. Phase III DEFINITY Clinical Investigators. Contrast material-enhanced abdominal US examinations with DMP 115 (DEFINITY) provides additional diagnostic information with potential for changes in patient management. Acad Radiol 2002; 91: S243-S245.
16. Mor-Avi V, Caiani EG, Collins KA, Korcarz CE, Bednarz JE, Lang RM. Combined assessment of myocardial perfusion and regional left ventricular function by analysis of contrast-enhanced power modulation images. Circulation 2001; 104: 352-357.
17. Murthy TH, Locricchio E, Kuersten B, Li P, Baisch C, Vannan MA. Power Doppler myocardial contrast echocardiography using an improved multiple frame triggered Harmonic Angio technique. Echocardiography 2001; 18: 191-196.
18. Kitzman DW, Goldman ME, Gillam LD, Cohen JL, Aurigemma GP, Gottdiener JS. Efficacy and safety of the novel ultrasound contrast agent perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 2000; 86: 669-674.
19. Maruyama H, Matsutani S, Saisho H, Kamiyama N, Yuki H, Miyata K. Grey-scale contrast enhancement in rabbit liver with DMP115 at different acoustic power levels. Ultrasound Med Biol 2000; 26: 1429-1438.
20. Van den Engh GJ, Trask BJ, Gray JW. The binding kinetics and interaction of DNA fluorochromes used in the analysis of nuclei and chromosomes by flow cytometry. Histochemistry 1986; 84: 501-508.
21. Suematsu M, DeLano FA, Poole D, Engler RL, Miyasaka M, Zweifach BW, et al. Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation. Lab Invest 1994; 70: 684-695.
22. European Committee for Medical Ultrasound Safety (ECMUS). Acoustic cavitation and capillary bleeding. Eur J Ultrasound 1999; 9: 277-280.
23. Jochle K, Debus J, Lorenz WJ, Huber P. A new method of quantitative cavitation assessment in the field of a lithotripter. Ultrasound Med Biol 1996; 22: 329-338.
24. Kodama T, Takayama K. Dynamic behavior of bubbles during extracorporeal shock-wave lithotripsy. Ultrasound Med Biol 1998; 24: 723-738.
25. Zhong P, Zhou Y, Zhu S. Dynamics of bubble oscillation in constrained media and mechanisms of vessel rupture in SWL. Ultrasound Med Biol 2001; 27: 119-134.
26. Walker KW, Pantely GA, Sahn DJ. Ultrasound-mediated destruction of contrast agents: Effect of ultrasound intensity, exposure, and frequency. Invest Radiol 1997; 32: 728-734.
27. Carstensen EL, Gracewski S, Dalecki D. The search for cavitation in vivo. Ultrasound Med Biol 2000; 26: 1377-1385.
28. Miller DL, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci USA 2000; 97: 10179-10184.
29. Elfgang C, Eckert R, Lichtenberg-Frate H, Butterweck A, Traub O, Klein RA, et al. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 1995; 129: 805-817.
30. Harris AG, Steinbauer M, Leiderer R, Messmer K. Role of leukocyte plugging and edema in skeletal muscle ischemia-reperfusion injury. Am J Physiol 1997; 273: H989-H996.
31. Cormack DH. The circulatory system. In: Cormack DH, editor. Ham's histology, 9th edn. Philadelphia: JB Lippincott Company; 1987: 424-446.
32. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795-808.
33. Endl E, Steinbach P, Scharfe J, Fickweiler S, Worle K, Hofstadter F. Cell-type-specific response to shock waves of suspended or pelleted cells as analysed by flow cytometry or electrical cell volume determination. Ultrasound Med Biol 1996; 22: 515-525.
34. Brayman AA, Coppage ML, Vaidya S, Miller MW. Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound. Ultrasound Med Biol 1999; 25: 999-1008.
35. Miller DL, Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 2000; 26: 661-667.
36. Miller DL, Quddus J. Lysis and sonoporation of epidermoid and phagocytic monolayer cells by diagnostic ultrasound activation of contrast agent gas bodies. Ultrasound Med Biol 2001; 27: 1107-1113.
37. Moran CM, Anderson T, Pye SD, Sboros V, McDicken WN. Quantification of microbubble destruction of three fluorocarbon-filled ultrasonic contrast agents. Ultrasound Med Biol 2000; 4: 629-639.
38. Schlief R. Echo enhancement: Agents and techniques: Basic principles. Adv Echo-Contrast 1994; 4: 5-19.
39. Fritzsch T, Schartl M, Siegert J. Preclinical and clinical results with an ultrasonic contrast agent. Invest Radiol 1988; 23: 5.
40. Miller DL, Gies RA. Enhancement of ultrasonically induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents. Ultrasound Med Biol 1998; 24: 285-292.
41. Immer FF, Seiler AM, Aeschbacher BC, Mahler F, Saner H. Influence of the ultrasound contrast agent Levovist on human nailfold capillary microcirculation. Angiology 2000; 51: 123-129.
42. Schlachetzki F, Holscher T, Koch HJ, Draganski B, May A, Schuierer G, et al. Observation on the integrity of the blood-brain barrier after microbubble destruction by diagnostic transcranial color-coded sonography. J Ultrasound Med 2002; 21: 419-429.
43. Tiemann K, Lohmeier S, Kuntz S, Koster J, Pohl C, Bums P, et al. Real-time contrast echo assessment of myocardial perfusion at low emission power: First experimental and clinical results using power pulse inversion imaging. Echocardiography 1999; 16: 799-809.
44. Masugata H, Peters B, Lafitte S, Strachan GM, Ohmori K, DeMaria AN. Quantitative assessment of myocardial perfusion during graded coronary stenosis by real-time myocardial contrast echo refilling curves. J Am Coll Cardiol 2001; 37: 262-269.